Nano-X Imaging (NNOX) Expected to Announce Earnings on Monday

Nano-X Imaging (NASDAQ:NNOX) is expected to post its Q4 2025 results before the market opens on Monday, April 6th. Analysts expect Nano-X Imaging to post earnings of ($0.15) per share and revenue of $3.9940 million for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Tuesday, April 7, 2026 at 12:30 PM ET.

Nano-X Imaging Price Performance

NASDAQ:NNOX opened at $2.41 on Friday. The stock has a market capitalization of $157.57 million, a price-to-earnings ratio of -1.83 and a beta of 1.39. Nano-X Imaging has a 52 week low of $2.11 and a 52 week high of $5.86. The firm has a 50 day moving average of $2.49 and a 200 day moving average of $3.17.

Wall Street Analyst Weigh In

NNOX has been the topic of a number of recent analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Nano-X Imaging in a research report on Monday, December 29th. D. Boral Capital restated a “buy” rating and set a $5.00 target price on shares of Nano-X Imaging in a research note on Tuesday, March 3rd. Finally, Cantor Fitzgerald raised Nano-X Imaging to a “strong-buy” rating in a research report on Wednesday, March 4th. Three equities research analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $5.00.

Institutional Investors Weigh In On Nano-X Imaging

Several institutional investors and hedge funds have recently made changes to their positions in NNOX. Weiss Asset Management LP acquired a new position in shares of Nano-X Imaging in the 4th quarter valued at $8,424,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Nano-X Imaging by 232.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,160,806 shares of the company’s stock valued at $10,793,000 after purchasing an additional 1,510,806 shares during the period. State Street Corp raised its stake in shares of Nano-X Imaging by 1.2% in the fourth quarter. State Street Corp now owns 1,176,202 shares of the company’s stock worth $3,293,000 after purchasing an additional 14,422 shares during the last quarter. UBS Group AG raised its stake in shares of Nano-X Imaging by 68.8% in the third quarter. UBS Group AG now owns 1,086,645 shares of the company’s stock worth $4,021,000 after purchasing an additional 442,899 shares during the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of Nano-X Imaging by 4.8% during the fourth quarter. Geode Capital Management LLC now owns 824,594 shares of the company’s stock worth $2,309,000 after purchasing an additional 37,436 shares during the period. 21.49% of the stock is currently owned by institutional investors and hedge funds.

About Nano-X Imaging

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.